![](/img/cover-not-exists.png)
Studies on Financial Reporting, Disclosure and Corporate Governance || Discussion of Competitive Costs of Disclosure by Biotech IPOs
Paul HribarVolume:
42
Language:
english
Journal:
Journal of Accounting Research
DOI:
10.2307/3542365
Date:
May, 2004
File:
PDF, 1.02 MB
english, 2004